Kristin Josic

发表

A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE).

Jennifer K. Sun, Judy E. Kim, L. Aiello, 2021, Ophthalmology. Retina.

Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments

Jennifer K. Sun, F. Ferris, E. Chew, 2021, Translational vision science & technology.

Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.

Jennifer K. Sun, Daniel F. Martin, L. Jampol, 2021, JAMA ophthalmology.

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).

Jennifer K. Sun, M. Elman, M. Maguire, 2020, Ophthalmology.

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.

Jennifer K. Sun, Daniel F. Martin, L. Jampol, 2023, JAMA.

Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to eETDRS Protocol Visual Acuity Assessment.

Jennifer K. Sun, M. Maguire, Daniel F. Martin, 2022, Ophthalmology.